Fluicell
0.097 SEK +6.37%4 investors are following this company
Fluicell is a biotechnology company. The company conducts research and development in processing the composition of cells in the development of new pharmaceuticals. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and finally process cells. In addition, there is expertise in 2D / 3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
FLUI
Daily low / high price
0.089 / 0.098
SEK
Market cap
46.37M SEK
Turnover
612.02K SEK
Volume
6.5M
Financial calendar
Interim report
2024-08-16
Interim report
2024-11-15
Annual report
2025-02-21
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 12.2 % | 12.2 % |
Viola Vitalis AB | 4.6 % | 4.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Fluicells beviljas patent i USA för plattformen Nexocyte
Styrelsen i Fluicell beslutar om riktad nyemission av aktier till garant
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools